US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 0.6000
- 0.00000.00%
Close Jul 18 16:00 ET
1.70MMarket Cap-38P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.6000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.83MShares16.720052wk High-0.09P/B1.49MFloat Cap0.475052wk Low--Dividend TTM2.49MShs Float417.5600Historical High--Div YieldTTM0.00%Amplitude0.4750Historical Low--Avg Price1Lot Size
Aslan Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -68.00%18.4M | -62.65%21.25M | -62.65%21.25M | -40.80%40.82M | -47.59%40.94M | -34.22%57.5M | -36.89%56.9M | -36.89%56.9M | -31.40%68.95M | -17.00%78.12M |
| -Cash and cash equivalents | -68.00%18.4M | -62.65%21.25M | -62.65%21.25M | -29.32%40.82M | -33.51%40.94M | -33.00%57.5M | -36.89%56.9M | -36.89%56.9M | -42.54%57.75M | -34.58%61.58M |
| -Short-term investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.2M | --16.54M |
| Receivables | ---- | --171.44K | --171.44K | ---- | --12M | ---- | --0 | --0 | ---- | ---- |
| -Accounts receivable | ---- | ---- | ---- | ---- | --12M | ---- | ---- | ---- | ---- | ---- |
| -Other receivables | ---- | --171.44K | --171.44K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Prepaid assets | ---- | -31.94%2.71M | -31.94%2.71M | ---- | ---- | ---- | 10.06%3.98M | 10.06%3.98M | ---- | 264.79%2.24M |
| Other current assets | -16.54%2.18M | ---- | ---- | 7.72%3.47M | --2.14M | -11.84%2.61M | ---- | ---- | --3.23M | ---- |
| Total current assets | -65.77%20.58M | -60.36%24.13M | -60.36%24.13M | -38.63%44.29M | -31.46%55.08M | -33.48%60.11M | -35.08%60.88M | -35.08%60.88M | -29.19%72.17M | -15.17%80.36M |
| Non current assets | ||||||||||
| Net PPE | -15.22%176.39K | -11.44%259.25K | -11.44%259.25K | -9.68%340.39K | 11.94%123.07K | 23.61%208.07K | 25.79%292.74K | 25.79%292.74K | 32.62%376.87K | -67.55%109.94K |
| -Gross PPE | -15.22%176.39K | -11.44%259.25K | -11.44%259.25K | -9.68%340.39K | 11.94%123.07K | 23.61%208.07K | 25.79%292.74K | 25.79%292.74K | 32.62%376.87K | -67.55%109.94K |
| Goodwill and other intangible assets | -85.73%686 | -70.60%1.72K | -70.60%1.72K | -60.01%2.75K | -52.18%3.78K | -46.16%4.81K | -41.38%5.84K | -41.38%5.84K | -37.50%6.87K | -34.29%7.9K |
| Investments and advances | 8,096.16%235.57K | 2,643.30%235.57K | 2,643.30%235.57K | --0 | --0 | -100.88%-2.95K | -98.26%8.59K | -98.26%8.59K | -91.59%54.1K | -83.84%132.25K |
| Total non current assets | 96.57%412.65K | 61.65%496.53K | 61.65%496.53K | -21.63%343.14K | -49.28%126.84K | -59.12%209.93K | -58.35%307.16K | -58.35%307.16K | -85.04%437.84K | -80.61%250.08K |
| Total assets | -65.20%20.99M | -59.75%24.63M | -59.75%24.63M | -38.53%44.64M | -31.52%55.21M | -33.63%60.32M | -35.27%61.19M | -35.27%61.19M | -30.75%72.61M | -16.05%80.61M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -2.75%12.01M | -27.20%11M | -27.20%11M | -50.97%6.75M | -21.88%8.72M | 36.64%12.35M | 160.84%15.11M | 160.84%15.11M | 137.61%13.77M | 139.13%11.16M |
| -accounts payable | -3.64%9.66M | -38.06%7.92M | -38.06%7.92M | -59.95%4.42M | -33.23%6.3M | 36.25%10.02M | 310.18%12.78M | 310.18%12.78M | 284.06%11.04M | 361.35%9.44M |
| -Other payable | 1.11%2.35M | 32.53%3.08M | 32.53%3.08M | -14.57%2.33M | 40.51%2.41M | 38.36%2.32M | -13.11%2.33M | -13.11%2.33M | -6.67%2.72M | -34.45%1.72M |
| Current accrued expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 14.04%195.31K |
| Current debt and capital lease obligation | -31.94%7.32M | -74.55%2.03M | -74.55%2.03M | 4,776.49%13.79M | 26,738.34%13.45M | 8,515.90%10.75M | 3,899.77%7.96M | 3,899.77%7.96M | -18.36%282.74K | -82.18%50.12K |
| -Current debt | -32.44%7.17M | -76.77%1.8M | -76.77%1.8M | --13.49M | --13.38M | --10.61M | --7.75M | --7.75M | ---- | ---- |
| -Current capital lease obligation | 5.06%150.24K | 4.88%226.19K | 4.88%226.19K | 6.00%299.69K | 36.11%68.21K | 14.63%143.01K | 8.31%215.67K | 8.31%215.67K | 35.40%282.74K | -82.18%50.12K |
| Other current liabilities | 93.19%280.65K | -2.02%88.39K | -2.02%88.39K | 205.49%439.03K | 1,734.43%2.19M | -36.12%145.27K | -59.61%90.21K | -59.61%90.21K | --143.71K | --119.35K |
| Current liabilities | -15.65%19.6M | -43.38%13.11M | -43.38%13.11M | 47.78%20.98M | 111.35%24.36M | 147.57%23.24M | 264.38%23.16M | 264.38%23.16M | 131.15%14.19M | 125.12%11.53M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -28.83%19.35M | -16.38%24.8M | -16.38%24.8M | -32.50%24.54M | -32.79%24.48M | -25.34%27.19M | -3.89%29.66M | -3.89%29.66M | 17.98%36.35M | 138.38%36.42M |
| -Long term debt | -28.83%19.35M | -16.38%24.8M | -16.38%24.8M | -32.50%24.54M | -32.79%24.48M | -25.34%27.19M | -3.89%29.66M | -3.89%29.66M | 18.22%36.35M | 139.37%36.42M |
| Total non current liabilities | -28.83%19.35M | -16.38%24.8M | -16.38%24.8M | -32.50%24.54M | -32.79%24.48M | -25.34%27.19M | -3.89%29.66M | -3.89%29.66M | 17.98%36.35M | 134.21%36.42M |
| Total liabilities | -22.75%38.95M | -28.22%37.91M | -28.22%37.91M | -9.95%45.52M | 1.86%48.84M | 10.09%50.43M | 41.94%52.82M | 41.94%52.82M | 36.78%50.55M | 131.96%47.95M |
| Shareholders'equity | ||||||||||
| Share capital | 2.47%65.19M | 1.45%63.93M | 1.45%63.93M | 1.32%63.85M | 1.08%63.7M | 0.95%63.62M | 0.00%63.02M | 0.00%63.02M | 0.00%63.02M | 0.01%63.02M |
| -common stock | 2.47%65.19M | 1.45%63.93M | 1.45%63.93M | 1.32%63.85M | 1.08%63.7M | 0.95%63.62M | 0.00%63.02M | 0.00%63.02M | 0.00%63.02M | 0.01%63.02M |
| Retained earnings | -11.26%-330.99M | -15.33%-321.07M | -15.33%-321.07M | -17.12%-309.09M | -18.35%-299.38M | -23.99%-297.5M | -22.63%-278.39M | -22.63%-278.39M | -21.94%-263.91M | -21.72%-252.98M |
| Paid-in capital | 1.57%247.78M | 8.88%243.79M | 8.88%243.79M | 9.60%244.54M | 8.72%242.23M | 9.80%243.95M | 1.10%223.91M | 1.10%223.91M | 4.69%223.13M | 1.11%222.8M |
| Gains losses not affecting retained earnings | 131.64%56.62K | 131.64%56.62K | 131.64%56.62K | 0.00%-178.95K | 0.00%-178.95K | 0.00%-178.95K | 0.00%-178.95K | 0.00%-178.95K | -102.19%-178.95K | 0.00%-178.95K |
| Other equity interest | ---- | ---- | ---- | ---- | ---- | --1 | ---- | ---- | ---- | ---- |
| Total stockholders'equity | -281.64%-17.96M | -258.84%-13.29M | -258.84%-13.29M | -104.00%-881.73K | -80.50%6.37M | -78.06%9.89M | -85.40%8.37M | -85.40%8.37M | -67.50%22.06M | -56.65%32.67M |
| Noncontrolling interests | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Total equity | -281.64%-17.96M | -258.84%-13.29M | -258.84%-13.29M | -104.00%-881.73K | -80.50%6.37M | -78.06%9.89M | -85.40%8.37M | -85.40%8.37M | -67.50%22.06M | -56.65%32.67M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data